Levels of CD3+CD8+ CTLs and activated CTLs are higher in healthy mice (Day 0, before implantation of mouse breast cancer cells), decreased in tumor‐carrying mice (Day 8, after tumor growth), then returned to higher level after resection of cancer (Day 28). The gene discussed is CD8A; the disease is breast carcinoma.